| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CTP synthase activity | 3.70e-05 | 2 | 122 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | sucrose transmembrane transporter activity | 2.20e-04 | 4 | 122 | 2 | GO:0008515 | |
| GeneOntologyMolecularFunction | sucrose:proton symporter activity | 2.20e-04 | 4 | 122 | 2 | GO:0008506 | |
| GeneOntologyMolecularFunction | oligosaccharide transmembrane transporter activity | 2.20e-04 | 4 | 122 | 2 | GO:0015157 | |
| GeneOntologyMolecularFunction | disaccharide transmembrane transporter activity | 2.20e-04 | 4 | 122 | 2 | GO:0015154 | |
| GeneOntologyMolecularFunction | sucrose:monoatomic cation symporter activity | 2.20e-04 | 4 | 122 | 2 | GO:0009669 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.74e-04 | 296 | 122 | 8 | GO:0015291 | |
| GeneOntologyMolecularFunction | ligase activity | 7.05e-04 | 174 | 122 | 6 | GO:0016874 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 7.24e-04 | 29 | 122 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 8.22e-04 | 119 | 122 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 1.01e-03 | 8 | 122 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | carbohydrate:proton symporter activity | 1.01e-03 | 8 | 122 | 2 | GO:0005351 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 1.01e-03 | 8 | 122 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | rRNA binding | 1.40e-03 | 79 | 122 | 4 | GO:0019843 | |
| GeneOntologyCellularComponent | cytoophidium | 1.03e-04 | 3 | 123 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | microbody | 3.98e-04 | 162 | 123 | 6 | GO:0042579 | |
| GeneOntologyCellularComponent | peroxisome | 3.98e-04 | 162 | 123 | 6 | GO:0005777 | |
| HumanPheno | Elevated circulating creatinine concentration | 3.34e-06 | 52 | 42 | 6 | HP:0003259 | |
| HumanPheno | Abnormal circulating creatinine concentration | 6.39e-06 | 58 | 42 | 6 | HP:0012100 | |
| Domain | GATase | 2.63e-06 | 5 | 121 | 3 | PF00117 | |
| Domain | GATASE_TYPE_1 | 5.23e-06 | 6 | 121 | 3 | PS51273 | |
| Domain | GATASE | 5.23e-06 | 6 | 121 | 3 | IPR017926 | |
| Domain | - | 3.08e-05 | 10 | 121 | 3 | 3.40.50.880 | |
| Domain | CTP_synthase_N | 4.16e-05 | 2 | 121 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 4.16e-05 | 2 | 121 | 2 | IPR033828 | |
| Domain | CTP_synthase | 4.16e-05 | 2 | 121 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 4.16e-05 | 2 | 121 | 2 | PF06418 | |
| Domain | Class_I_gatase-like | 5.59e-05 | 12 | 121 | 3 | IPR029062 | |
| Domain | NHR2 | 1.24e-04 | 3 | 121 | 2 | PF08788 | |
| Domain | Anion_exchange_CS | 1.24e-04 | 3 | 121 | 2 | IPR018241 | |
| Domain | CBFA2T1/2/3 | 1.24e-04 | 3 | 121 | 2 | IPR013289 | |
| Domain | NHR2 | 1.24e-04 | 3 | 121 | 2 | IPR014896 | |
| Domain | zf-MYND | 3.24e-04 | 21 | 121 | 3 | PF01753 | |
| Domain | ZF_MYND_1 | 3.73e-04 | 22 | 121 | 3 | PS01360 | |
| Domain | Znf_MYND | 3.73e-04 | 22 | 121 | 3 | IPR002893 | |
| Domain | ZF_MYND_2 | 3.73e-04 | 22 | 121 | 3 | PS50865 | |
| Domain | TAFH | 4.11e-04 | 5 | 121 | 2 | SM00549 | |
| Domain | TAFH_NHR1 | 4.11e-04 | 5 | 121 | 2 | IPR003894 | |
| Domain | Anion_exchange | 4.11e-04 | 5 | 121 | 2 | IPR001717 | |
| Domain | TAFH | 4.11e-04 | 5 | 121 | 2 | PS51119 | |
| Domain | TAFH | 4.11e-04 | 5 | 121 | 2 | PF07531 | |
| Domain | ANION_EXCHANGER_2 | 8.56e-04 | 7 | 121 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 8.56e-04 | 7 | 121 | 2 | PS00219 | |
| Domain | - | TRIT1 NDST2 DNM1L UPF1 TEP1 GEM CTPS2 DDX50 CTPS1 CHST7 HYDIN ATP5F1A DYNC1H1 | 1.10e-03 | 746 | 121 | 13 | 3.40.50.300 |
| Domain | - | 1.29e-03 | 73 | 121 | 4 | 2.60.120.260 | |
| Domain | - | 1.45e-03 | 9 | 121 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 1.45e-03 | 9 | 121 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 1.45e-03 | 9 | 121 | 2 | PF07565 | |
| Domain | ARM-type_fold | 1.65e-03 | 339 | 121 | 8 | IPR016024 | |
| Domain | PTrfase/Anion_transptr | 1.81e-03 | 10 | 121 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.81e-03 | 10 | 121 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 1.81e-03 | 10 | 121 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.81e-03 | 10 | 121 | 2 | IPR011531 | |
| Domain | Inhibin_asu | 3.10e-03 | 13 | 121 | 2 | IPR002405 | |
| Domain | Galactose-bd-like | 3.26e-03 | 94 | 121 | 4 | IPR008979 | |
| Domain | P-loop_NTPase | TRIT1 NDST2 DNM1L UPF1 TEP1 GEM CTPS2 DDX50 CTPS1 CHST7 HYDIN ATP5F1A DYNC1H1 | 3.39e-03 | 848 | 121 | 13 | IPR027417 |
| Domain | PI3/4_kinase_CS | 4.14e-03 | 15 | 121 | 2 | IPR018936 | |
| Domain | Galactosyl_T | 4.71e-03 | 16 | 121 | 2 | PF01762 | |
| Domain | - | 4.71e-03 | 16 | 121 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 4.71e-03 | 16 | 121 | 2 | SM00146 | |
| Domain | Glyco_trans_31 | 4.71e-03 | 16 | 121 | 2 | IPR002659 | |
| Domain | PI3_PI4_kinase | 5.95e-03 | 18 | 121 | 2 | PF00454 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 5.95e-03 | 18 | 121 | 2 | PS00754 | |
| Domain | PI3_4_KINASE_1 | 5.95e-03 | 18 | 121 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.95e-03 | 18 | 121 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.95e-03 | 18 | 121 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.95e-03 | 18 | 121 | 2 | PS50290 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 INTS1 NAGLU SLC10A3 SPPL2B TEP1 ITGB4 SLC6A8 BMP8B SLC45A3 PIK3CD NBEAL2 PKD1 PRKDC SLC45A1 SNAPC4 TTC38 DYNC1H1 | 8.15e-08 | 1105 | 124 | 18 | 35748872 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RPS9 INTS1 NAGLU PCDHA5 NCL LRRC47 GMPS PTPRN2 ALDH16A1 PKD1 PRKDC CTPS1 DYNC1H1 | 2.45e-06 | 736 | 124 | 13 | 29676528 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 MYCBP2 HDHD5 RPS9 INTS1 NCL UPF1 LRRC47 GMPS MRPS7 CTPS2 ATXN10 PRKDC CTPS1 SNRPD2 ATP5F1A DYNC1H1 | 2.48e-06 | 1257 | 124 | 17 | 37317656 |
| Pubmed | RPS9 NCL UPF1 MRPS7 DDX50 PRKDC SNRPD2 MRPL11 ATP5F1A DYNC1H1 | 3.16e-06 | 425 | 124 | 10 | 21081503 | |
| Pubmed | 7.23e-06 | 197 | 124 | 7 | 31620119 | ||
| Pubmed | NCL UPF1 LRRC47 MRPS7 UBA52 MEX3A SNRPD2 MRPL11 ATP5F1A BICC1 | 7.50e-06 | 469 | 124 | 10 | 37314180 | |
| Pubmed | MPO RPS9 NCL LRRC47 DDX50 ATXN10 PRKDC MRPL11 ATP5F1A DYNC1H1 | 9.68e-06 | 483 | 124 | 10 | 36912080 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPS9 NCL UPF1 GMPS UBA52 DDX50 PRKDC CTPS1 SNRPD2 MRPL11 ATP5F1A DYNC1H1 | 1.00e-05 | 714 | 124 | 12 | 28302793 |
| Pubmed | HDHD5 RPS9 DNM1L NCL UPF1 LRRC47 MRPS7 PRKDC MRPL11 ATP5F1A DYNC1H1 | 1.09e-05 | 601 | 124 | 11 | 33658012 | |
| Pubmed | Immunolocalization of AE2 anion exchanger in rat and mouse epididymis. | 1.26e-05 | 2 | 124 | 2 | 10491632 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29717938 | ||
| Pubmed | Cardiac hypertrophy in anion exchanger 1-null mutant mice with severe hemolytic anemia. | 1.26e-05 | 2 | 124 | 2 | 17056673 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9463357 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26275098 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8682296 | ||
| Pubmed | Cloning and structural characterization of a human non-erythroid band 3-like protein. | 1.26e-05 | 2 | 124 | 2 | 3015590 | |
| Pubmed | Lipid metabolism in dopaminergic neurons influences light entrainment. | 1.26e-05 | 2 | 124 | 2 | 36815399 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 38407308 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21518865 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21277400 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27650074 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 3182834 | ||
| Pubmed | Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin. | 1.26e-05 | 2 | 124 | 2 | 26183533 | |
| Pubmed | Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway. | 1.26e-05 | 2 | 124 | 2 | 31940275 | |
| Pubmed | Molecular and cellular biology of the erythrocyte anion exchanger (AE1). | 1.26e-05 | 2 | 124 | 2 | 8434259 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31520365 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19596993 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10022820 | ||
| Pubmed | Conditional Deletion of Cytoplasmic Dynein Heavy Chain in Postnatal Photoreceptors. | 1.26e-05 | 2 | 124 | 2 | 34807236 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17690150 | ||
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 1.26e-05 | 2 | 124 | 2 | 20739275 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.31e-05 | 84 | 124 | 5 | 25670202 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 2.73e-05 | 333 | 124 | 8 | 32665550 | |
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 21082674 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 3.03e-05 | 166 | 124 | 6 | 35687106 | |
| Pubmed | EFCAB5 MYCBP2 RPS9 DNM1L NCL MRPS7 ATXN10 PRKDC CTPS1 SNRPD2 ATP5F1A DYNC1H1 | 3.41e-05 | 809 | 124 | 12 | 32129710 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 16179339 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 9076678 | ||
| Pubmed | CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene family. | 3.77e-05 | 3 | 124 | 2 | 9790752 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 34837834 | ||
| Pubmed | Pendrin: an apical Cl-/OH-/HCO3- exchanger in the kidney cortex. | 3.77e-05 | 3 | 124 | 2 | 11208611 | |
| Pubmed | Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons. | 3.77e-05 | 3 | 124 | 2 | 25339743 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28450740 | ||
| Pubmed | Requirement of Bmp8b for the generation of primordial germ cells in the mouse. | 3.77e-05 | 3 | 124 | 2 | 10894154 | |
| Pubmed | BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. | 3.77e-05 | 3 | 124 | 2 | 22579288 | |
| Pubmed | The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. | 3.77e-05 | 3 | 124 | 2 | 8885865 | |
| Pubmed | Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. | 3.77e-05 | 3 | 124 | 2 | 11784057 | |
| Pubmed | Identification of the carbonic anhydrase II binding site in the Cl(-)/HCO(3)(-) anion exchanger AE1. | 3.77e-05 | 3 | 124 | 2 | 10820026 | |
| Pubmed | Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a. | 3.77e-05 | 3 | 124 | 2 | 25451979 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 38243303 | ||
| Pubmed | Expression and function of bicarbonate/chloride exchangers in the preimplantation mouse embryo. | 3.77e-05 | 3 | 124 | 2 | 7592657 | |
| Pubmed | Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). | 3.77e-05 | 3 | 124 | 2 | 12925636 | |
| Pubmed | Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression. | 3.77e-05 | 3 | 124 | 2 | 25888842 | |
| Pubmed | Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. | 3.77e-05 | 3 | 124 | 2 | 17652430 | |
| Pubmed | Identification of a band-3 binding site near the N-terminus of erythrocyte membrane protein 4.2. | 3.77e-05 | 3 | 124 | 2 | 7626035 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28466093 | ||
| Pubmed | CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. | 3.77e-05 | 3 | 124 | 2 | 19112095 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 16567633 | ||
| Pubmed | Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease. | 3.77e-05 | 3 | 124 | 2 | 29513071 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 36026451 | ||
| Pubmed | Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. | 3.77e-05 | 3 | 124 | 2 | 26429886 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 32135568 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 4.07e-05 | 175 | 124 | 6 | 25756610 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPS9 ISOC1 NCL UPF1 ITGB4 LRRC47 MRPS7 DDX50 PRKDC CTPS1 TACSTD2 SNRPD2 MRPL11 ATP5F1A DYNC1H1 | 4.32e-05 | 1257 | 124 | 15 | 36526897 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HDHD5 RPS9 ISOC1 NCL UPF1 CCDC51 LRRC47 GMPS MRPS7 CTPS2 PRKDC CTPS1 SNRPD2 MRPL11 ATP5F1A DYNC1H1 | 4.49e-05 | 1415 | 124 | 16 | 28515276 |
| Pubmed | RPS9 ATG2B ISOC1 DNM1L UPF1 EFR3A GMPS PRKDC CTPS1 ATP5F1A DYNC1H1 | 4.86e-05 | 708 | 124 | 11 | 39231216 | |
| Pubmed | PDXDC1 GPX1 NCL UPF1 LRRC47 QSOX1 MRPS7 PRKDC SNRPD2 ATP5F1A DYNC1H1 | 5.05e-05 | 711 | 124 | 11 | 33022573 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 5.72e-05 | 272 | 124 | 7 | 25315684 | |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 6.18e-05 | 374 | 124 | 8 | 19625176 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 RPS9 GPX1 ISOC1 DNM1L NCL LRRC47 GMPS CTPS2 ALDH16A1 ALAD ATXN10 PRKDC CTPS1 SNRPD2 DYNC1H1 | 6.24e-05 | 1455 | 124 | 16 | 22863883 |
| Pubmed | 6.27e-05 | 276 | 124 | 7 | 28319085 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 6.43e-05 | 190 | 124 | 6 | 15161933 | |
| Pubmed | 6.68e-05 | 488 | 124 | 9 | 31324722 | ||
| Pubmed | 7.03e-05 | 381 | 124 | 8 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 7.16e-05 | 382 | 124 | 8 | 19170196 | |
| Pubmed | 7.29e-05 | 383 | 124 | 8 | 29331416 | ||
| Pubmed | Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins. | 7.53e-05 | 4 | 124 | 2 | 14703694 | |
| Pubmed | Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine. | 7.53e-05 | 4 | 124 | 2 | 11842009 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 34362731 | ||
| Pubmed | β4 Integrin signaling induces expansion of prostate tumor progenitors. | 7.53e-05 | 4 | 124 | 2 | 23348745 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9434160 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 8843393 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 16966434 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 25922073 | ||
| Pubmed | Nucleolin-Mediated RNA Localization Regulates Neuron Growth and Cycling Cell Size. | 7.53e-05 | 4 | 124 | 2 | 27477284 | |
| Pubmed | Epistasis of oxidative stress-related enzyme genes on modulating the risks in oral cavity cancer. | 7.53e-05 | 4 | 124 | 2 | 20643115 | |
| Pubmed | MYCBP2 RPS9 INTS1 DNM1L NCL SLC4A2 DDX50 NBEAL2 ALDH16A1 ATXN10 PRKDC CTPS1 ATP5F1A DYNC1H1 | 7.54e-05 | 1168 | 124 | 14 | 19946888 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 8.01e-05 | 287 | 124 | 7 | 36180891 | |
| Pubmed | 8.29e-05 | 64 | 124 | 4 | 22865885 | ||
| Pubmed | HDHD5 RPS9 ISOC1 NCL UPF1 GMPS MRPS7 UBA52 CTPS2 PRKDC CTPS1 SNRPD2 MRPL11 ATP5F1A ANAPC4 | 8.49e-05 | 1335 | 124 | 15 | 29229926 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 8.53e-05 | 200 | 124 | 6 | 35546148 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MPO MYCBP2 RPS9 ISOC1 NCL UPF1 LRRC47 GMPS MRPS7 DDX50 PRKDC CTPS1 SNRPD2 ATP5F1A DYNC1H1 | 9.84e-05 | 1353 | 124 | 15 | 29467282 |
| Pubmed | PDXDC1 RPS9 DNM1L UPF1 LRRC47 GMPS ATXN10 PRKDC CTPS1 DYNC1H1 | 1.01e-04 | 638 | 124 | 10 | 33239621 | |
| Pubmed | 1.19e-04 | 411 | 124 | 8 | 36652389 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MPO NAGLU PBLD SLC44A4 OGN QSOX1 PROM1 UBA52 ALAD TTC38 ATP5F1A DYNC1H1 GP2 | 1.21e-04 | 1070 | 124 | 13 | 23533145 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | PEX12 DNM1L SLC10A3 NCL TRIM6 ITGB4 SLC4A2 PRICKLE3 ALDH16A1 ARMC5 PKD1 ATP5F1A | 1.22e-04 | 925 | 124 | 12 | 28986522 |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 7661851 | ||
| Pubmed | Keratins modulate colonocyte electrolyte transport via protein mistargeting. | 1.25e-04 | 5 | 124 | 2 | 15007064 | |
| Pubmed | Regional expression of MTG genes in the developing mouse central nervous system. | 1.25e-04 | 5 | 124 | 2 | 19618476 | |
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 18586123 | ||
| GeneFamily | Solute carriers | SLC10A3 SLC44A4 SLC22A17 SLC4A1 SLC4A2 SLC6A3 SLC6A8 SLC45A3 SLC45A1 SLC2A11 | 2.67e-05 | 395 | 90 | 10 | 752 |
| GeneFamily | Zinc fingers MYND-type | 1.49e-04 | 21 | 90 | 3 | 87 | |
| GeneFamily | Beta 3-glycosyltransferases | 2.24e-04 | 24 | 90 | 3 | 426 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.31e-03 | 11 | 90 | 2 | 455 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-08 | 178 | 124 | 8 | eafacc8cd3e986d6ca309e05b6e241331a584fa5 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-08 | 178 | 124 | 8 | 6a5c31e976852edc7d9e899da8e2a1bf23d36759 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-08 | 178 | 124 | 8 | 370749834a11d981e9ede26d5f63f0ecb551c015 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-08 | 179 | 124 | 8 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-08 | 179 | 124 | 8 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-08 | 179 | 124 | 8 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.43e-08 | 194 | 124 | 8 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.87e-07 | 178 | 124 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-07 | 186 | 124 | 7 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-07 | 186 | 124 | 7 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-07 | 186 | 124 | 7 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | SMG-Goblet|World / shred by cell class for bronchial biopsy | 9.57e-07 | 187 | 124 | 7 | 5178118bdec91495253c88f58fd908cf831de7ef | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 191 | 124 | 7 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-06 | 191 | 124 | 7 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | (10)_Ciliated-(0)_Reference|(10)_Ciliated / shred by cell type by condition | 1.22e-06 | 194 | 124 | 7 | f9d5bf6baddbd88947e6a740805962109649ed3b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.04e-06 | 143 | 124 | 6 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.03e-06 | 161 | 124 | 6 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 169 | 124 | 6 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 169 | 124 | 6 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.95e-06 | 169 | 124 | 6 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-06 | 175 | 124 | 6 | e4c9b3c6bde390a3892b112b673f93e118220eb9 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 9.71e-06 | 175 | 124 | 6 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-06 | 175 | 124 | 6 | 4d36da7399c62c170cb603957b35a35efb2c3fbe | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.71e-06 | 175 | 124 | 6 | 2c39c1b112e873403ad2add8595cc256bf0b97a6 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 9.71e-06 | 175 | 124 | 6 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 179 | 124 | 6 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Mast_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.10e-05 | 179 | 124 | 6 | 6153e7a0eeae83e7d88f1a20093bf2113e8d66b1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 180 | 124 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 181 | 124 | 6 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 181 | 124 | 6 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 183 | 124 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-05 | 183 | 124 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.37e-05 | 186 | 124 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.37e-05 | 186 | 124 | 6 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 124 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 124 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.41e-05 | 187 | 124 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-05 | 187 | 124 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.46e-05 | 188 | 124 | 6 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.50e-05 | 189 | 124 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 1.50e-05 | 189 | 124 | 6 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 1.55e-05 | 190 | 124 | 6 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.59e-05 | 191 | 124 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-05 | 191 | 124 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.59e-05 | 191 | 124 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-05 | 191 | 124 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.59e-05 | 191 | 124 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 191 | 124 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 191 | 124 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 191 | 124 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.59e-05 | 191 | 124 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.69e-05 | 193 | 124 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 193 | 124 | 6 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.74e-05 | 194 | 124 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.74e-05 | 194 | 124 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.79e-05 | 195 | 124 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.85e-05 | 196 | 124 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.85e-05 | 196 | 124 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.85e-05 | 196 | 124 | 6 | 092caba6726d1acd409a8be335100764d0724e64 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-05 | 197 | 124 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.90e-05 | 197 | 124 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-05 | 197 | 124 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-05 | 197 | 124 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 1.92e-05 | 117 | 124 | 5 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-05 | 198 | 124 | 6 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-05 | 198 | 124 | 6 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 1.95e-05 | 198 | 124 | 6 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-05 | 198 | 124 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 199 | 124 | 6 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.01e-05 | 199 | 124 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 199 | 124 | 6 | f894c88ecc7fd0edca28587801fa59352d10f750 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 199 | 124 | 6 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 199 | 124 | 6 | 2b754670fe77c2301afcdcfc73a1e52cc0cd1de3 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.01e-05 | 199 | 124 | 6 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 124 | 6 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.07e-05 | 200 | 124 | 6 | ac5843142e0f8a5bcd2c3a784ea13b2f955a32fd | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.07e-05 | 200 | 124 | 6 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Biopsy_IPF|World / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 124 | 6 | 4de8c4789fb64250cb1dca94c108d39ab119bab4 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 2.07e-05 | 200 | 124 | 6 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.17e-05 | 120 | 124 | 5 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-05 | 144 | 124 | 5 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.19e-05 | 144 | 124 | 5 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | Ciliated_cells-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.55e-05 | 146 | 124 | 5 | 20f080318e9cbfd9b8b90a5e9f704d6d85b969ee | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 149 | 124 | 5 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.11e-05 | 149 | 124 | 5 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.71e-05 | 152 | 124 | 5 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 152 | 124 | 5 | 525d65c5c8e5580947367afdb1f6e68b49e9e5bb | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-05 | 154 | 124 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-05 | 154 | 124 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| Disease | anemia (implicated_via_orthology) | 3.79e-07 | 15 | 123 | 4 | DOID:2355 (implicated_via_orthology) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 4.00e-06 | 26 | 123 | 4 | DOID:9351 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 6.52e-05 | 19 | 123 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | noise-induced hearing loss | 1.71e-04 | 5 | 123 | 2 | EFO_1001254 | |
| Disease | Colorectal Carcinoma | MPO FRMPD2 NTNG1 RUNX1T1 CBFA2T3 SLC44A4 LRRC47 PROM1 PTPRN2 DCHS1 ANAPC4 | 1.77e-04 | 702 | 123 | 11 | C0009402 |
| Disease | VACTERL association (implicated_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | matrix metalloproteinase 7 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0010591 | |
| Disease | Hematological Disease | 4.75e-04 | 8 | 123 | 2 | C0018939 | |
| Disease | Combined oxidative phosphorylation deficiency | 4.95e-04 | 37 | 123 | 3 | cv:C4540031 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 6.09e-04 | 9 | 123 | 2 | C0085413 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 6.09e-04 | 9 | 123 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | schizophrenia, type 2 diabetes mellitus | 7.72e-04 | 43 | 123 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | Paranoia | 9.25e-04 | 11 | 123 | 2 | C1456784 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 1.30e-03 | 13 | 123 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | leukemia (is_implicated_in) | 1.30e-03 | 13 | 123 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.52e-03 | 14 | 123 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.99e-03 | 16 | 123 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_implicated_in) | 1.99e-03 | 16 | 123 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 2.25e-03 | 17 | 123 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | juvenile dermatomyositis | 3.12e-03 | 20 | 123 | 2 | EFO_0000557 | |
| Disease | cardiovascular system disease (is_implicated_in) | 3.44e-03 | 21 | 123 | 2 | DOID:1287 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IRRVIGDFGVPIAIL | 931 | P04920 | |
| GGLLGQRIVRLLVEE | 11 | P26439 | |
| TVGREGRDRLLVQLP | 656 | Q9UJX5 | |
| VLESLVGRDLLPRGT | 41 | O00429 | |
| QVAGLRGPVLRLREP | 646 | Q8IZ83 | |
| VLVRINLVGGPLERI | 871 | Q96NH3 | |
| LRRVIGDFGVPISIL | 601 | P02730 | |
| QLGRRLVREGVISVP | 61 | Q8N9P6 | |
| FPGLLERVIDLLRVI | 326 | Q9UBB4 | |
| ELQRRLGPRGLVVLG | 61 | P07203 | |
| NVPELVSELVLRGGR | 181 | O96024 | |
| VALQRAVRLGDPRVI | 366 | Q8IYW2 | |
| RTEVRRLGGILPLVT | 146 | Q96C12 | |
| GVESARVRIRELLPL | 191 | Q9H694 | |
| VVLSPRRLELVQLLG | 201 | Q9H816 | |
| DAPRVRAGIIQVLLE | 306 | Q14156 | |
| DPVQIGRLIGRLELS | 281 | Q96BY7 | |
| AIGRPLGEVVTLRVL | 1216 | Q76LX8 | |
| VDSLVPIGRGQRELI | 196 | P25705 | |
| IRAVLGAVPRGRLLV | 366 | P54802 | |
| ELGISLRPDGRVDIR | 261 | P30039 | |
| ILRIEVGRFPVLEGQ | 311 | O00391 | |
| RRARQTEDIPIILVG | 176 | P55040 | |
| GRRLVEDVARLLQVP | 526 | Q92932 | |
| GVKRRRLIPEALLAG | 71 | Q5T5X7 | |
| EGNGIAPLVRLLRIS | 1031 | Q7Z5J8 | |
| SLPDVLGVAGLVRRR | 91 | Q9NPA2 | |
| LRRGPDGSISRIIVE | 86 | Q6W4X9 | |
| RELRLEVIARGPLPG | 2896 | Q96JQ0 | |
| LRGLQRTLPLVVILG | 16 | Q9H3H1 | |
| QRLLQGARILGIPVI | 141 | Q96CN7 | |
| IVEALLGVPLIRSGL | 296 | Q8NES3 | |
| VERIRAGGPQLHLVI | 191 | Q9H6Y5 | |
| RIRVGTQLRVLGPED | 1336 | Q8N201 | |
| SPEIGERVRTLVLGL | 141 | Q06455 | |
| RPLVEEGLRCVLIFG | 66 | P13716 | |
| RRELLLTGPGLEERV | 21 | Q8N1G4 | |
| RIRRLGEPEDSLGIV | 241 | P0CG22 | |
| GIEVAVESLLPGIRR | 1091 | Q9P266 | |
| LRGLGRVHLLEVEQP | 946 | A9Z1Z3 | |
| LLESLRGPALDVIRV | 206 | Q96BY2 | |
| RLVLALALVRPRAVG | 11 | Q6UW60 | |
| LGLAPRELAERGVRI | 56 | Q9Y5H3 | |
| FILAGIRLPIVLVGI | 376 | P09131 | |
| RVVLEGGIDPILRGL | 536 | P05164 | |
| RLLEEGVLRQIPVVG | 631 | Q6P996 | |
| LARVLDLGPITRRGA | 491 | P55259 | |
| VIARDGRLLPGDIIL | 311 | Q8TBB1 | |
| RIEEIRLEGNPIVLG | 266 | P20774 | |
| VLQEVRRVLRPGGVL | 156 | Q6UX53 | |
| PLLAVAGSRGIIRII | 161 | O75530 | |
| LGLELAELVPRLFRV | 51 | Q9Y5H7 | |
| ISPEIGERVRTLVLG | 191 | O75081 | |
| TLHLVLRLRGGIIEP | 66 | P62987 | |
| LRLRGGIIEPSLRQL | 71 | P62987 | |
| QVARIPVIRRVLDGG | 1006 | P16144 | |
| REIEGRAIRLELQGP | 546 | P19338 | |
| LERVPGIFISRLVRG | 186 | Q9NPB6 | |
| RENLGRGIVRIFPVT | 166 | O43900 | |
| RRLIVIVVPESLGFG | 446 | Q9HB29 | |
| FERLVVLGIRPIRLQ | 696 | Q92900 | |
| IVVPLRERTGEALGV | 1251 | A4FU69 | |
| ILGREIRLPLRIKGE | 441 | Q4G0P3 | |
| VIERVGRRVLLIGGY | 331 | Q9BYW1 | |
| ILGRELGLPEELVSR | 421 | P49915 | |
| EELRLLLPRVRVGEA | 26 | O95273 | |
| TGPGQVARLVLERRV | 1021 | Q68DX3 | |
| VALLRIRQGDLLVVP | 516 | Q6NUI2 | |
| RRDVQREILAVLGLP | 41 | Q7Z5Y6 | |
| IRNGIDILVGTPGRI | 256 | Q9BQ39 | |
| LAGIISLNRVRIEIP | 391 | Q9NPG1 | |
| EIERILGVRLQAGLR | 906 | Q14204 | |
| GRRDLLPTVRIVAGV | 501 | Q6UWL6 | |
| RLVAGPLVLVLILGV | 251 | Q53GD3 | |
| EVVLVGGSTRIPRIR | 401 | P48723 | |
| IVRQVRAERGLRGVP | 321 | Q9NQR7 | |
| RRDVQREILAVLGLP | 41 | P34820 | |
| GRRRPFILVLAIGAL | 186 | Q9Y2W3 | |
| ILQVLGRGLVILEPL | 561 | Q8N309 | |
| RALPELLGVTLGLVV | 4021 | P98161 | |
| IDPSRIRIERVIGAG | 626 | Q9UF33 | |
| DLRIRLLRPAVGEIF | 261 | Q9Y2I2 | |
| LRKPEVGGVIRAIVR | 11 | Q9Y3B7 | |
| ALLRRLVRIGVLDEG | 76 | P46781 | |
| RLTVVVLEARGLRPG | 261 | Q8NBV8 | |
| ALGVRRAVLQLPGLT | 16 | Q9Y2R9 | |
| LRGDSVIVVLRNPLI | 101 | P62316 | |
| EVIPTTVRGRGLGLI | 436 | Q8WUG5 | |
| VPHVLVRRGLLGRDL | 16 | Q96ER9 | |
| GLDLRVRGEPLQVER | 241 | P09758 | |
| EAGRGQVLVPRVLAL | 96 | Q6ZNJ1 | |
| LDIDGVLVRGHRVIP | 51 | Q9BXW7 | |
| VLGGGILDRLRPNII | 236 | O43490 | |
| LPRQDALVLEGVRIG | 66 | Q9Y6U7 | |
| VRELRGLGLSPDLVV | 201 | P17812 | |
| VIRRHRLEEGRGPLV | 866 | O75592 | |
| VLVVLLVRGVLLPGA | 271 | P48029 | |
| IKNEGRRVGIPRVIL | 156 | B9EJG8 | |
| PLLRLAGVQLGRLTV | 191 | O00623 | |
| RVVPGRGICLDLAIL | 481 | Q96JT2 | |
| IAVRGLAPEQRVTLR | 21 | Q8N9L9 | |
| QGALVRRVFLLGVPR | 146 | Q6UX72 | |
| ILRILRLPELGDLGQ | 6 | Q9UKU0 | |
| DVRLLDLGVLVPLLR | 251 | Q9NS84 | |
| VRALRGLGLSPDLIV | 201 | Q9NRF8 | |
| LLLSELLGRRAPVVV | 321 | P49842 | |
| LLGRRAPVVVRLGLT | 326 | P49842 | |
| SLAGQRVPVDRVILL | 771 | Q99973 | |
| ARELPRGVLEGLRQV | 61 | Q86UD0 | |
| RDLVVRGIPETLRGE | 481 | Q0IIM8 | |
| RLDGVIPLARGGVVR | 586 | Q9NX95 | |
| IRVRVPYRVVGLVVG | 226 | A1L020 | |
| LLRGVTLPGAIDGIR | 281 | Q01959 | |
| GARGLLIVSRERLVP | 111 | Q8TCT7 | |
| VLRRARLPTVVQDLG | 256 | P52849 | |
| LPTGDRTGLIEVVLR | 816 | O00329 | |
| LRLEGVRVILAPEAA | 1256 | Q9BZZ2 | |
| FVGLRDGVLRVPLER | 541 | Q9P283 | |
| QPVGIRLLEEALLRL | 2886 | P78527 | |
| ELLLPIRYRIVQLGG | 396 | Q5R3I4 | |
| RPGARALRLVLGIVL | 251 | Q9UKP6 | |
| EGGRRLLTVPVETVL | 661 | Q5SXM2 | |
| LLLPGEAEVLVRGLR | 6 | O75800 | |
| ARGVDPVGRLLLVRV | 261 | Q9UP52 | |
| PVGRLLLVRVGVISF | 266 | Q9UP52 | |
| ERDIIEGGSLRIPLQ | 391 | Q9UPU9 | |
| RLRALVVIPIIFGIL | 191 | P25942 | |
| NIVRRLREVVLGPGK | 76 | Q9C030 | |
| VIRQGEVIDIRGPIR | 341 | Q5T124 |